NMN and NAD+: The Complete Guide to Longevity's Hottest Supplements

Why NAD+ Matters

Some supplements are fashionable. NAD+ is foundational.

Nicotinamide adenine dinucleotide — NAD+ — is present in every living cell in your body. It's not a vitamin or a herb or a botanical extract. It's a coenzyme: a molecular workhorse that enables hundreds of biological reactions simultaneously, all day, every day. Without it, cellular energy production would stop. DNA repair would stall. The longevity-linked proteins called sirtuins would go silent.

The interest in NMN — its most accessible dietary precursor — is therefore not just another wellness trend. It's grounded in real biochemistry, a growing body of human clinical trials, and the work of researchers like David Sinclair at Harvard, who has spent decades studying NAD+ biology and publicly advocates for NMN supplementation himself.

That said, the science is still developing. This guide covers what we actually know, where the evidence is strong, and where the excitement may be getting ahead of the data.

---

What Is NAD+ and What Does It Do?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in virtually every cell in the human body. It participates in more than 500 enzymatic reactions — arguably making it one of the most important molecules in human biology.

Its roles span several critical areas:

Energy metabolism. NAD+ is essential to glycolysis, the TCA cycle, and the electron transport chain — the three central pathways through which cells convert food into ATP (cellular energy). In its reduced form (NADH), it carries electrons through these reactions. Without NAD+, mitochondria cannot produce meaningful amounts of energy.

DNA repair. NAD+ is a required substrate for PARP enzymes (poly ADP-ribose polymerases), which detect and repair DNA strand breaks. Every time your DNA is damaged by UV radiation, oxidative stress or metabolic errors — which happens constantly — PARP enzymes consume NAD+ to fix it. As NAD+ becomes scarce, DNA repair efficiency declines.

Sirtuin activation. Sirtuins are a family of proteins (SIRT1 through SIRT7) linked to longevity, metabolic regulation, inflammation control and stress resistance. They are entirely dependent on NAD+ as a co-substrate. No NAD+, no sirtuin activity. This is the core reason NAD+ has become so central to longevity research.

Circadian rhythm regulation. NAD+ levels naturally fluctuate across the 24-hour cycle, and this oscillation helps govern the body's internal clock. Declining NAD+ is thought to contribute to the disrupted circadian rhythms commonly seen in aging.

---

Why NAD+ Declines with Age

Here is the core problem: NAD+ levels in human tissue decline dramatically with age. Studies in various human tissues have found NAD+ concentrations roughly 50% lower in people over 60 compared to people in their 20s and 30s. This isn't a slow drift — it's a meaningful biological shift that tracks closely with the onset of many age-related changes.

The decline is driven by several converging mechanisms:

CD38 enzyme activity increases. CD38 is a NAD+-consuming enzyme that rises sharply with age and chronic inflammation. It functions as a kind of NAD+ drain, degrading it faster than the body can replenish it. Research has shown that blocking CD38 in aged mice restores NAD+ levels and reverses some hallmarks of metabolic aging.

NAMPT activity declines. NAMPT is the rate-limiting enzyme in the primary NAD+ synthesis pathway (the salvage pathway). Its activity decreases with age, reducing the body's capacity to produce NMN — the direct precursor to NAD+.

Chronic inflammation increases consumption. Low-grade, persistent inflammation (sometimes called "inflammaging") drives PARP enzyme activity, which burns through NAD+ continuously. As inflammation increases with age, so does NAD+ consumption.

The result is a progressive NAD+ deficit — less energy production capacity, slower DNA repair, quieter sirtuins, more disrupted sleep, and declining metabolic resilience. Restoring NAD+ levels is the central hypothesis behind NMN supplementation.

---

What Is NMN?

NMN stands for nicotinamide mononucleotide. It is a molecule naturally found in small amounts in foods including edamame, broccoli, avocado, cucumber and beef — though at concentrations far too low to meaningfully raise NAD+ levels through diet alone.

Biochemically, NMN sits one step away from NAD+ in the salvage pathway. Once absorbed, it's converted to NAD+ by NMNAT enzymes (nicotinamide mononucleotide adenylyltransferases) — a relatively direct and efficient process. This is why NMN has attracted more attention than other NAD+ precursors: it bypasses the rate-limiting NAMPT step that becomes increasingly sluggish with age.

A 2025 study published in Science Advances shed important light on how orally administered NMN is actually metabolised in vivo. Rather than being directly absorbed into the bloodstream, most oral NMN appears to undergo gut microbiota-mediated conversion to nicotinic acid (NA), which then enters the Preiss-Handler pathway to form NAD+. This explains why liposomal NMN — which is encapsulated to survive digestive degradation — has shown superior performance in recent clinical trials.

---

NMN vs NR: Which Is Better?

NR (nicotinamide riboside) is the other major NAD+ precursor on the supplement market, and the comparison with NMN is one of the most commonly asked questions in this space.

The short answer: both reliably raise NAD+ levels. The differences are real but more nuanced than most reviews suggest.

A landmark 2025 trial published in Nature Metabolism (Christen et al.) directly compared NR, NMN and nicotinamide in humans. Both NR and NMN sustainably doubled circulating NAD+ over 14 days, while nicotinamide did not sustain levels comparably. The study also confirmed that both NR and NMN work primarily via gut microbiota-mediated conversion — reinforcing the case for liposomal or enteric-coated formulations that bypass degradation.

The practical takeaway: if you want well-established safety data and lower cost, NR is a solid choice. If you want broader tissue reach, more recent and rapidly growing research, and are willing to invest in quality (particularly liposomal forms), NMN has a strong case.

---

The Research: What Human Trials Actually Show

The research base for NMN has grown substantially between 2022 and 2026. Here's an honest overview of what the best trials have found.

NAD+ elevation is consistently demonstrated. Across virtually every human study, oral NMN supplementation measurably increases blood NAD+ levels. This is the most replicated finding in the field. A 2024 multicenter RCT (n=80 healthy middle-aged adults, 300/600/900mg doses) found statistically significant NAD+ increases at both day 30 and day 60 across all NMN groups versus placebo. NAD+ levels were highest in the 600mg and 900mg groups.

Physical performance improvements are emerging. The same multicenter trial found that walking distance during the six-minute walking test was significantly higher in the 300mg, 600mg and 900mg groups versus placebo at both timepoints. Biological age (measured via Aging.Ai 3.0) increased significantly in the placebo group but remained stable in all NMN-treated groups — a meaningful finding, though one that warrants replication.

A May 2024 randomised, double-blind, placebo-controlled trial in healthy older adults (65–75 years, 250mg/day, 12 weeks) found significantly shorter 4-metre walking times in the NMN group versus placebo, alongside improved sleep quality scores on the Pittsburgh Sleep Quality Index.

A 2024 meta-analysis confirmed muscle and liver benefits. Covering 9 studies and 412 participants, the analysis found significant effects of NMN on gait speed (SMD: 0.34 m/s, p=0.033), improved liver enzyme levels (ALT), and reduced insulin resistance — particularly at lower doses. These are clinically meaningful endpoints.

Liposomal NMN outperforms standard NMN. A February 2025 randomised, placebo-controlled trial found that liposomal NMN (350mg/day, 4 weeks) significantly increased NAD+ levels compared to non-liposomal NMN and placebo. Not all NMN products are equivalent.

Where the evidence is still limited. A 2024 systematic review of glucose and lipid metabolism outcomes found that while NAD+ levels consistently increase, most primary metabolic outcomes (fasting glucose, triglycerides, LDL cholesterol) were not significantly different between NMN and placebo. NMN's benefits may be more relevant to physical performance, aging biomarkers and cellular energy than to acute metabolic correction.

No human longevity trial exists. Long-term data in humans (years, not weeks) is entirely absent. This is the field's most significant limitation.

---

Reported Benefits of NMN Supplementation

Drawing from both clinical trials and the broader research picture, the areas of most consistent evidence include:

Energy and exercise capacity. Improved walking performance and physical endurance have appeared in multiple RCTs, likely reflecting restored mitochondrial efficiency in muscle tissue.

Improved sleep quality. The 2024 older-adult trial noted significantly better sleep scores in the NMN group, connecting to NAD+'s role in circadian rhythm regulation.

Muscle mass and function. A 2025 systematic review and meta-analysis found trends toward preservation of muscle mass in older adults, though results were not uniformly significant.

Biological age stability. The multicenter RCT's finding that biological age increased in the placebo group but not the NMN groups is intriguing, though this used a computational algorithm rather than direct biological measurement.

Vascular health. A 12-week double-blind placebo-controlled trial found a trend toward reduced arterial stiffness (pulse wave velocity), consistent with NAD+'s role in vascular endothelial function.

---

NMN in Europe: The Legal Landscape

The EU regulatory picture for NMN is more favourable than often assumed.

NMN is not scheduled as a controlled substance anywhere in the EU. It is currently sold legally as a dietary supplement across the Netherlands, Germany, Belgium and most other EU member states — in contrast to the United States, where the FDA's 2022 ruling restricted NMN supplement sales due to its designation as an investigational new drug.

For European consumers, quality NMN supplements from reputable EU brands are legal to buy and use. What matters is choosing products with verified purity, declared NMN content, and ideally third-party testing.

Cibdol is a Switzerland-based brand with strong EU distribution, offering a reliably pure NMN supplement as an accessible entry point for European users.

---

How to Choose NMN

Purity declaration. Look for products declaring at least 99% NMN purity, with certificates of analysis (COAs) available confirming this.

Liposomal vs standard. The February 2025 RCT demonstrating liposomal superiority is a meaningful finding. Liposomal NMN protects the molecule from digestive degradation and improves cellular delivery. If budget allows, liposomal formulations are worth the premium.

Branded ingredients. Look for established ingredients: Uthever® and Longevir™ are standardised, third-party-verified forms with clinical research behind them.

Dose declaration. The label should clearly state the mg of NMN per serving. Avoid products listing NMN in a proprietary blend.

EU-sourced or EU-regulated brands. For European buyers, brands manufactured in GMP-certified facilities and regulated under EU food supplement law offer stronger quality assurance.

---

Dosage: What the Evidence Suggests

Start at 250–300mg/day for 4–8 weeks to assess response. Take in the morning with food — NAD+ production connects to circadian rhythms and morning dosing aligns with the body's natural NAD+ oscillation.

---

Stacking NMN

NMN + Resveratrol (the Sinclair protocol). NMN raises NAD+ (the fuel for sirtuins), while resveratrol activates SIRT1 directly. The synergy is theoretically sound; human evidence for added benefit beyond either alone is still accumulating.

NMN + TMG (trimethylglycine). At higher doses (500mg+), NMN can increase methylation demand. TMG (500–1000mg/day) acts as a methyl donor, potentially preventing homocysteine accumulation. A useful precautionary addition for higher-dose protocols.

NMN + Spermidine. Both operate on complementary longevity pathways — NMN through NAD+/sirtuin axis, spermidine through autophagy induction. A logical multi-pathway longevity protocol.

NMN + Exercise. Exercise independently raises NAD+ and activates sirtuins. NMN supplementation appears to show amplified benefits in physically active individuals.

---

Safety and Side Effects

NMN has a reassuring short-term safety record. Across trials including doses up to 900mg/day over 60 days, no serious adverse events have been reported. Standard blood markers have remained stable across studies.

The most commonly reported effects at higher doses are mild and transient: occasional nausea, flushing, or gastrointestinal discomfort.

Long-term safety data is limited. All published trials have been relatively short (4–24 weeks). People who choose to take NMN long-term should be aware that multi-year human safety data does not yet exist.

Who should be cautious: People with cancer or a history of cancer should consult their oncologist (theoretical concern that raising NAD+ broadly could support cancer cell energy alongside healthy cells). People on medications that interact with NAD+ metabolism should take medical advice. Pregnant and breastfeeding women should avoid NMN due to insufficient safety data.

---

Where to Buy

---

FAQ

Does NMN actually work?

NMN consistently and reliably raises blood NAD+ levels in humans — this is the most well-replicated finding across clinical trials. Whether that NAD+ elevation translates into meaningful longevity benefits over the long term is still unknown. The short-term benefits for physical performance, sleep and energy are better established than the anti-aging claims.

Is NMN legal in Europe?

Yes. NMN is legal to buy and use as a dietary supplement across the EU, including the Netherlands, Germany, Belgium and France. This differs from the US, where the FDA's 2022 ruling restricted supplement sales.

What is the difference between NMN and NR?

Both are NAD+ precursors. NMN is one step closer to NAD+ in the biochemical pathway; NR must first be converted to NMN before becoming NAD+. Both raise blood NAD+ effectively. A 2025 Nature Metabolism trial confirmed both are comparably effective at doubling circulating NAD+ over two weeks. NR has a longer research history and is cheaper; NMN has a rapidly growing body of recent RCTs and may have broader tissue reach.

How long does NMN take to work?

Blood NAD+ levels begin rising within days. Most clinical trials measure outcomes at 4 and 12 weeks. Subjective benefits, if any, are typically reported in the 4–8 week window. Allow 8–12 weeks of consistent use before evaluating results.

Should I take NMN with resveratrol?

David Sinclair's protocol combines both. The theoretical rationale is sound — NMN fuels sirtuins, resveratrol activates them. There is no human trial specifically comparing the combination against either alone. Both appear safe together at standard doses.

Is liposomal NMN worth the extra cost?

A February 2025 RCT found liposomal NMN produced significantly higher NAD+ increases than non-liposomal NMN. If maximising NAD+ elevation is the goal, the liposomal premium appears justified by the data.

---

This content is for informational purposes only and is not medical advice. Consult a healthcare professional before starting any supplement, particularly if you have a medical condition or are taking medication.

---

Related articles:

• Spermidine: The Autophagy Activator Taking Europe by Storm
• How to Build a Supplement Stack: A Step-by-Step Framework
• What Are Adaptogens? A Guide to Nature's Stress Fighters
• The Best Natural Sleep Supplements: A Science-Based Guide